-
Company Insights
Innovation and Patenting activity of Victoria~s Secret & Co Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Victoria~s Secret & Co Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will...
-
Product Insights
NewLikelihood of Approval Analysis for Hemophagocytic Lymphohistiocytosis
Overview How likely is it that the drugs in Hemophagocytic Lymphohistiocytosis will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Hemophagocytic Lymphohistiocytosis Overview Hemophagocytic lymphohistiocytosis (HLH), also known as hemophagocytic or haemophagocytic...
-
Product Insights
NewLikelihood of Approval Analysis for Carcinoid Tumor
Overview How likely is it that the drugs in Carcinoid Tumor will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Carcinoid Tumor Overview Carcinoid tumors are slow-growing tumors arising from neuroendocrine cells...
-
Product Insights
NewLikelihood of Approval Analysis for Axillary Hyperhidrosis
Overview How likely is it that the drugs in Axillary Hyperhidrosis will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Axillary Hyperhidrosis Overview Axillary hyperhidrosis also referred to as excessive underarm sweating....
-
Product Insights
NewLikelihood of Approval Analysis for Sudoriferous (Sweat) Gland Disorders
Overview How likely is it that the drugs in Sudoriferous (Sweat) Gland Disorders will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Sudoriferous (Sweat) Gland Disorders Overview Sweat glands, also known as...
-
Product Insights
NewLikelihood of Approval Analysis for Hypersecretory Conditions
Overview How likely is it that the drugs in Hypersecretory Conditions will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Hypersecretory Conditions Overview Hypersecretory Condition is a group of disorders characterized by...
-
Product Insights
NewLikelihood of Approval Analysis for Metastatic Adenocarcinoma of The Pancreas
Overview How likely is it that the drugs in Metastatic Adenocarcinoma of The Pancreas will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Metastatic Adenocarcinoma of The Pancreas Overview Metastatic adenocarcinoma is...
-
Product Insights
NewLikelihood of Approval Analysis for Neuroendocrine Gastroenteropancreatic Tumors (GEP-NET)
Overview How likely is it that the drugs in Neuroendocrine Gastroenteropancreatic Tumors (GEP-NET) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Neuroendocrine Gastroenteropancreatic Tumors (GEP-NET) Overview Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are...
-
Product Insights
NewLikelihood of Approval Analysis for Conjunctivitis
Overview How likely is it that the drugs in Conjunctivitis will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Conjunctivitis Overview Conjunctivitis, commonly known as "pink eye", refers to inflammation of the...
-
Product Insights
NewLikelihood of Approval Analysis for Hepadnaviridae Infections
Overview How likely is it that the drugs in Hepadnaviridae Infections will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Hepadnaviridae Infections Overview Hepadnaviridae infections are caused by a family of viruses...